A dynamic clinical development analysis of vaccine and drug candidates against COVID-19 was also in place in April 2020. Several existing antiviral drugs are being evaluated in the treatment of COVID-19, including remdesivir, chloroquine and hydroxychloroquine , lopinavir/ritonavir and lopinavir/ritonavir plus interferon beta.
Ukaguzi changamani wa maendeleo ya kliniki ya chanjo ya na dawa za COVID-19 zinaendelea, kuanzia April 2020. Dawa kadhaa za kuzuia virusi zinatathminiwa kwa ajili ya matibabu ya COVID-19, ikiwemo remdesivir, chloroquine na hydroxychloroquine, lopinavir/ritonavir na lopinavir/ritonavir pamoja na interferon beta.